JYHZ2100602 | 替格瑞洛片 | ticagrelor | Tablet | Chemical Drugs | License Renew | 2021-08-11 | | | | | view |
JYHZ2100601 | 替格瑞洛片 | ticagrelor | Tablet | Chemical Drugs | License Renew | 2021-08-11 | | | | | view |
JYHZ1700031 | 替格瑞洛片 | ticagrelor | Tablet | Chemical Drugs | License Renew | 2017-06-26 | AstraZeneca AB | AstraZeneca AB | Certificate Issued | 2017-09-12 | view |
JYHZ1700030 | 替格瑞洛片 | ticagrelor | Tablet | Chemical Drugs | License Renew | 2017-06-26 | AstraZeneca AB | AstraZeneca AB | Certificate Issued | 2017-09-12 | view |
JYHF1700105 | 替格瑞洛片 | ticagrelor | Tablet | Chemical Drugs | Supplementary Application | 2017-11-06 | 阿斯利康投资(中国)有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2017-12-04 | view |
JYHB2400401 | 替格瑞洛片 | ticagrelor | Tablet | Chemical Drugs | Supplementary Application | 2024-07-27 | | AstraZeneca AB | | | view |
JYHB2400400 | 替格瑞洛片 | ticagrelor | Tablet | Chemical Drugs | Supplementary Application | 2024-07-27 | | AstraZeneca AB | | | view |
JYHB2200505 | 替格瑞洛片 | ticagrelor | Tablet | Chemical Drugs | Supplementary Application | 2022-09-15 | | AstraZeneca AB | | | view |
JYHB2200504 | 替格瑞洛片 | ticagrelor | Tablet | Chemical Drugs | Supplementary Application | 2022-09-15 | | AstraZeneca AB | | | view |
JYHB2200106 | 替格瑞洛片 | ticagrelor | Tablet | Chemical Drugs | Supplementary Application | 2022-03-01 | | AstraZeneca AB | | | view |
JYHB2200105 | 替格瑞洛片 | ticagrelor | Tablet | Chemical Drugs | Supplementary Application | 2022-03-01 | | AstraZeneca AB | | | view |
JYHB2101440 | 替格瑞洛片 | ticagrelor | Tablet | Chemical Drugs | Supplementary Application | 2021-09-23 | | AstraZeneca AB | | | view |
JYHB2101439 | 替格瑞洛片 | ticagrelor | Tablet | Chemical Drugs | Supplementary Application | 2021-09-23 | | AstraZeneca AB | | | view |
JYHB2001799 | 替格瑞洛片 | ticagrelor | Tablet | Chemical Drugs | Supplementary Application | 2020-09-17 | 阿斯利康制药有限公司 | Astrazeneca Pharmaceutical Co Ltd | Filed | 2020-09-30 | view |
JYHB2001084 | 替格瑞洛片 | ticagrelor | Tablet | Chemical Drugs | Supplementary Application | 2020-06-28 | | AstraZeneca AB | Filed | 2020-06-30 | view |
JYHB2001083 | 替格瑞洛片 | ticagrelor | Tablet | Chemical Drugs | Supplementary Application | 2020-06-28 | | AstraZeneca AB | Filed | 2020-06-30 | view |
JYHB2000355 | 替格瑞洛片 | ticagrelor | Tablet | Chemical Drugs | Supplementary Application | 2020-03-31 | | AstraZeneca AB | Filed | 2020-04-16 | view |
JYHB1901014 | 替格瑞洛片 | ticagrelor | Tablet | Chemical Drugs | Supplementary Application | 2019-09-04 | | AstraZeneca AB | Certificate Issued | 2019-12-30 | view |
JYHB1901013 | 替格瑞洛片 | ticagrelor | Tablet | Chemical Drugs | Supplementary Application | 2019-09-04 | | AstraZeneca AB | Certificate Issued | 2019-12-30 | view |
JYHB1900837 | 替格瑞洛片 | ticagrelor | Tablet | Chemical Drugs | Supplementary Application | 2019-07-17 | | AstraZeneca AB | In Review | 2019-07-16 | view |